UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Immediate Versus Delayed Treatment with EGFR Tyrosine Kinase Inhibitors after First-line Therapy in Advanced Non-small-cell Lung Cancer

Chinese journal of cancer research, 2011-06, Vol.23 (2), p.112-117

2011

Volltextzugriff (PDF)

High Expression of ERCC1 Is a Poor Prognostic Factor in Chinese Patients with Non-small Cell Lung Cancer Receiving Cisplatin-based Therapy

Chinese journal of cancer research, 2010-12, Vol.22 (4), p.296-302

2010

Volltextzugriff (PDF)

A Phase II Clinical Trial of Celecoxib Combined with Platinum-Based Regimen as First-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer Patients with Cyclooxygenase-2 Positive Expression

Chinese journal of cancer research, 2009-03, Vol.21 (1), p.1-12

2009

Volltextzugriff (PDF)

Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)

Journal of hematology and oncology, 2022-07, Vol.15 (1), p.1-86, Article 86

2022

Volltextzugriff (PDF)

MAPK Pathway and TERT Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients: A Retrospective Study of 2,793 Cases

Clinical cancer research, 2017-10, Vol.23 (20), p.6120-6127

2017

Volltextzugriff (PDF)

miR‑222 regulates brain injury and inflammation following intracerebral hemorrhage by targeting ITGB8

Molecular medicine reports, 2020-03, Vol.21 (3), p.1145-1153

2020

Volltextzugriff (PDF)

A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2017-12, Vol.114, p.96-102

2017

Volltextzugriff (PDF)

Changes in clinical trials of cancer drugs in mainland China over the decade 2009–18: a systematic review

The lancet oncology, 2019-11, Vol.20 (11), p.e619-e626

2019

Volltextzugriff (PDF)

Impact of Bile Duct Tumor Thrombus on the Long-Term Surgical Outcomes of Hepatocellular Carcinoma Patients: A Propensity Score Matching Analysis

Annals of surgical oncology, 2022-02, Vol.29 (2), p.949-958

2022

Volltextzugriff (PDF)

Long-Term Outcomes of Anatomic Versus Nonanatomic Resection in Hepatocellular Carcinoma Patients with Bile Duct Tumor Thrombus: A Propensity Score Matching Analysis

Annals of surgical oncology, 2021-11, Vol.28 (12), p.7686-7695

2021

Volltextzugriff (PDF)

Systemic Inflammatory Biomarkers, Especially Fibrinogen to Albumin Ratio, Predict Prognosis in Patients with Pancreatic Cancer

Cancer Research and Treatment, 2021, 53(1), , pp.131-139

2021

Volltextzugriff (PDF)

A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: a survival cohort analysis

BMC cancer, 2017-03, Vol.17 (1), p.167-167, Article 167

2017

Volltextzugriff (PDF)

A nomogram based on combining systemic and hepatic inflammation markers for predicting microscopic bile duct tumour thrombus in hepatocellular carcinoma

BMC cancer, 2021-03, Vol.21 (1), p.272-272, Article 272

2021

Volltextzugriff (PDF)

Sphere-forming culture enriches liver cancer stem cells and reveals Stearoyl-CoA desaturase 1 as a potential therapeutic target

BMC cancer, 2019-08, Vol.19 (1), p.760-12, Article 760

2019

Volltextzugriff (PDF)

Prognostic factors in patients with thymoma who underwent surgery

World journal of surgical oncology, 2023-07, Vol.21 (1), p.203-203, Article 203

2023

Volltextzugriff (PDF)

PRMT1 enhances oncogenic arginine methylation of NONO in colorectal cancer

Oncogene, 2021-02, Vol.40 (7), p.1375-1389

2021

Volltextzugriff (PDF)

Outcomes of Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma Converted by Transcatheter Arterial Chemoembolization Combined with Lenvatinib plus Anti-PD-1 Antibodies: A Multicenter Retrospective Study

Liver cancer (Basel ), 2023-08, Vol.12 (3), p.229-237

2023

Volltextzugriff (PDF)

Neutrophil‐to‐Apolipoprotein A1 Ratio Predicted Overall Survival in Hepatocellular Carcinoma Receiving Transarterial Chemoembolization

The oncologist (Dayton, Ohio), 2021-08, Vol.26 (8), p.e1434-e1444

2021

Volltextzugriff (PDF)

IRF4 rearrangement may predict favorable prognosis in children and young adults with primary head and neck large B‐cell lymphoma

Cancer medicine (Malden, MA), 2023-05, Vol.12 (9), p.10684-10693

2023

Volltextzugriff (PDF)

Safety and clinical activity with an anti-PD-1 antibody JS001 in advanced melanoma or urologic cancer patients

Journal of hematology and oncology, 2019-01, Vol.12 (1), p.7-15, Article 7

2019

Volltextzugriff (PDF)

ASO Visual Abstract: Impact of Bile Duct Tumor Thrombus on the Long-Term Surgical Outcomes of Hepatocellular Carcinoma Patients—A Propensity Score-Matching Analysis

Annals of surgical oncology, 2021-12, Vol.28 (Suppl 3), p.771-771

2021

Volltextzugriff (PDF)

Single-Cell Characterization of Malignant Phenotypes and Developmental Trajectories of Adrenal Neuroblastoma

Cancer cell, 2020-11, Vol.38 (5), p.716-733.e6

2020

Volltextzugriff (PDF)

Imaging Features of Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: A Multicenter Study

Frontiers in oncology, 2021-11, Vol.11, p.723455-723455

2021

Volltextzugriff (PDF)

A multicenter clinical study: personalized medication for advanced gastrointestinal carcinomas with the guidance of patient-derived tumor xenograft (PDTX)

Journal of cancer research and clinical oncology, 2022-03, Vol.148 (3), p.673-684

2022

Volltextzugriff (PDF)

Investigations of the prognostic value of RUNX1 mutation in acute myeloid leukemia patients: Data from a real-world study

Leukemia research, 2024-04, Vol.139, p.107483-107483, Article 107483

2024

Volltextzugriff (PDF)

1 – 25 von 216

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(176)
Mit Volltextzugriff
(207)

Publikationsform

Artikel
(216)

Sprache

Englisch
(215)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Immediate Versus Delayed Treatment with EGFR Tyrosine Kinase Inhibitors after First-line Therapy in Advanced Non-small-cell Lung Cancer

High Expression of ERCC1 Is a Poor Prognostic Factor in Chinese Patients with Non-small Cell Lung Cancer Receiving Cisplatin-based Therapy

A Phase II Clinical Trial of Celecoxib Combined with Platinum-Based Regimen as First-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer Patients with Cyclooxygenase-2 Positive Expression

Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)

MAPK Pathway and TERT Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients: A Retrospective Study of 2,793 Cases

miR‑222 regulates brain injury and inflammation following intracerebral hemorrhage by targeting ITGB8

A comprehensive review of uncommon EGFR mutations in patients with non-small cell lung cancer

Changes in clinical trials of cancer drugs in mainland China over the decade 2009–18: a systematic review

Impact of Bile Duct Tumor Thrombus on the Long-Term Surgical Outcomes of Hepatocellular Carcinoma Patients: A Propensity Score Matching Analysis

Long-Term Outcomes of Anatomic Versus Nonanatomic Resection in Hepatocellular Carcinoma Patients with Bile Duct Tumor Thrombus: A Propensity Score Matching Analysis

Systemic Inflammatory Biomarkers, Especially Fibrinogen to Albumin Ratio, Predict Prognosis in Patients with Pancreatic Cancer

A genetic variant in long non-coding RNA MALAT1 associated with survival outcome among patients with advanced lung adenocarcinoma: a survival cohort analysis

A nomogram based on combining systemic and hepatic inflammation markers for predicting microscopic bile duct tumour thrombus in hepatocellular carcinoma

Sphere-forming culture enriches liver cancer stem cells and reveals Stearoyl-CoA desaturase 1 as a potential therapeutic target

Prognostic factors in patients with thymoma who underwent surgery

PRMT1 enhances oncogenic arginine methylation of NONO in colorectal cancer

Outcomes of Salvage Surgery for Initially Unresectable Hepatocellular Carcinoma Converted by Transcatheter Arterial Chemoembolization Combined with Lenvatinib plus Anti-PD-1 Antibodies: A Multicenter Retrospective Study

Neutrophil‐to‐Apolipoprotein A1 Ratio Predicted Overall Survival in Hepatocellular Carcinoma Receiving Transarterial Chemoembolization

IRF4 rearrangement may predict favorable prognosis in children and young adults with primary head and neck large B‐cell lymphoma

Safety and clinical activity with an anti-PD-1 antibody JS001 in advanced melanoma or urologic cancer patients

ASO Visual Abstract: Impact of Bile Duct Tumor Thrombus on the Long-Term Surgical Outcomes of Hepatocellular Carcinoma Patients—A Propensity Score-Matching Analysis

Single-Cell Characterization of Malignant Phenotypes and Developmental Trajectories of Adrenal Neuroblastoma

Imaging Features of Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: A Multicenter Study

A multicenter clinical study: personalized medication for advanced gastrointestinal carcinomas with the guidance of patient-derived tumor xenograft (PDTX)

Investigations of the prognostic value of RUNX1 mutation in acute myeloid leukemia patients: Data from a real-world study

Aktive Filter

Suchergebnisse filtern